Quantcast

Latest Raloxifene Stories

2004-12-01 06:00:13

Research and Markets (http://www.researchandmarkets.com/reports/c10315) has announced the addition of Commercial Insight: Osteoporosis and HRT - Novel Osteoporosis Drugs Counter Generic Threat While HRT Players Regroup and Move Forward to their offering The osteoporosis and HRT market was valued at $8.3 billion in 2003 and is forecast to grow to $17.9 billion by 2014, driven by a number of novel osteoporosis drug launches before 2009.

2004-11-30 18:00:11

A U.S. study of raloxifene found women had more than a 50 percent reduction in breast cancer incidence beyond the first four years of treatment.

2004-11-30 18:00:11

TUESDAY, Nov. 30 (HealthDayNews) -- If you're taking raloxifene (Evista) because you have osteoporosis, a new study finds a probable added benefit: The drug may also significantly reduce your risk of developing breast cancer. The study, which appears in the Dec.

2004-11-26 18:00:09

Dr. Jim Mitterando Q - I am 61 years old. Should I have a bone density test for osteoporosis and take calcium pills? A - Diagnosing and treating osteoporosis (thin bones) is somewhat controversial with many opinions and not much long-term data.


Word of the Day
bowerly
  • Large; stout; burly.
The word 'bowerly' is an alteration of 'burly'.